EP1161147A4 - Peptide mimics useful for treating disease - Google Patents

Peptide mimics useful for treating disease

Info

Publication number
EP1161147A4
EP1161147A4 EP98964947A EP98964947A EP1161147A4 EP 1161147 A4 EP1161147 A4 EP 1161147A4 EP 98964947 A EP98964947 A EP 98964947A EP 98964947 A EP98964947 A EP 98964947A EP 1161147 A4 EP1161147 A4 EP 1161147A4
Authority
EP
European Patent Office
Prior art keywords
treating disease
peptide mimics
mimics useful
useful
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98964947A
Other languages
German (de)
French (fr)
Other versions
EP1161147A1 (en
Inventor
Soldano Ferrone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New York Medical College
Original Assignee
New York Medical College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New York Medical College filed Critical New York Medical College
Publication of EP1161147A1 publication Critical patent/EP1161147A1/en
Publication of EP1161147A4 publication Critical patent/EP1161147A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001169—Tumor associated carbohydrates
    • A61K39/001171—Gangliosides, e.g. GM2, GD2 or GD3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
EP98964947A 1998-12-24 1998-12-24 Peptide mimics useful for treating disease Withdrawn EP1161147A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/027633 WO2000038515A1 (en) 1998-12-24 1998-12-24 Peptide mimics useful for treating disease

Publications (2)

Publication Number Publication Date
EP1161147A1 EP1161147A1 (en) 2001-12-12
EP1161147A4 true EP1161147A4 (en) 2002-07-24

Family

ID=22268554

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98964947A Withdrawn EP1161147A4 (en) 1998-12-24 1998-12-24 Peptide mimics useful for treating disease

Country Status (5)

Country Link
EP (1) EP1161147A4 (en)
JP (1) JP2002533357A (en)
AU (1) AU2016199A (en)
CA (1) CA2334958A1 (en)
WO (1) WO2000038515A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001026672A1 (en) * 1999-10-13 2001-04-19 Roswell Park Memorial Institute Induction of a strong immune response to a self-tumor associated antigen
EP1287831B1 (en) * 2001-09-03 2006-11-22 Bio Life Science Forschungs- und Entwicklungsges.m.b.H. Antigen mimotopes and vaccine against cancerous diseases
AU2003213700A1 (en) * 2002-03-01 2003-09-16 Applied Immune Technologies Immunogens for treatment of neoplastic and infectious disease
US6998237B1 (en) * 2002-07-11 2006-02-14 Health Research, Inc. GD3 peptide mimics
JP5836125B2 (en) * 2008-10-16 2015-12-24 ユニバーシティ オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション Fully human antibodies against high molecular weight melanoma-related antigens and uses thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989011296A1 (en) * 1988-05-17 1989-11-30 Raychaudhuri, Syamal Anti-idiotype antibodies to anti-human high molecular weight-melanoma associated antigen
EP0668350A1 (en) * 1994-02-16 1995-08-23 Akzo Nobel N.V. Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma
WO1997034613A1 (en) * 1996-03-19 1997-09-25 University Of Virginia Patent Foundation Peptides recognized by melanoma-specific a1-, a2- and a3-restricted cytotoxic lymphocytes, and uses therefor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5662907A (en) * 1992-08-07 1997-09-02 Cytel Corporation Induction of anti-tumor cytotoxic T lymphocytes in humans using synthetic peptide epitopes

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989011296A1 (en) * 1988-05-17 1989-11-30 Raychaudhuri, Syamal Anti-idiotype antibodies to anti-human high molecular weight-melanoma associated antigen
EP0668350A1 (en) * 1994-02-16 1995-08-23 Akzo Nobel N.V. Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma
WO1997034613A1 (en) * 1996-03-19 1997-09-25 University Of Virginia Patent Foundation Peptides recognized by melanoma-specific a1-, a2- and a3-restricted cytotoxic lymphocytes, and uses therefor

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
BAKKER A B H ET AL: "ANALOGUES OF CTL EPITOPES WITH IMPROVED MHC CLASS-I BINDING CAPACITY ELICIT ANTI-MELANOMA CTL RECOGNIZING THE WILD-TYPE EPITOPE", INTERNATIONAL JOURNAL OF CANCER, NEW YORK, NY, US, vol. 70, no. 3, 1997, pages 302 - 309, XP000917224, ISSN: 0020-7136 *
CORTESE R ET AL: "Identification of biologically active peptides using libraries displayed on phage", CURRENT OPINION IN BIOTECHNOLOGY, LONDON, GB, vol. 6, no. 1, 1995, pages 73 - 80, XP002107140, ISSN: 0958-1669 *
DYALL R ET AL: "HETEROCLITIC IMMUNIZATION INDUCES TUMOR IMMUNITY", JOURNAL OF EXPERIMENTAL MEDICINE, TOKYO, JP, vol. 188, no. 9, 2 November 1998 (1998-11-02), pages 1553 - 1561, XP002947142, ISSN: 0022-1007 *
HOESS R ET AL: "IDENTIFICATION OF A PEPTIDE WHICH BINDS TO THE CARBOHYDRATE-SPECIFIC MONOCLONAL ANTIBODY B3", GENE, ELSEVIER BIOMEDICAL PRESS. AMSTERDAM, NL, vol. 1, no. 128, 15 June 1993 (1993-06-15), pages 43 - 49, XP001071246, ISSN: 0378-1119 *
MITTELMAN A ET AL: "HUMAN HIGH MOLECULAR WEIGHT MELANOMA-ASSOCIATED ANTIGEN (HMW-MAA) MIMICRY BY MOUSE ANTI-IDIOTYPIC MONOCLONAL ANTIBODY MK2-23: INDUCTION OF HUMORAL ANTI-HMW-MAA IMMUNITY AND PROLONGATION OF SURVIVAL IN PATIENTS WITH STAGE IV MELANOMA", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 89, 1992, pages 466 - 470, XP000887127, ISSN: 0027-8424 *
PARKHURST ET AL: "Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues", JOURNAL OF IMMUNOLOGY, THE WILLIAMS AND WILKINS CO. BALTIMORE, US, vol. 157, 1996, pages 2539 - 2548, XP002096010, ISSN: 0022-1767 *
PARMIANI G: "Future perspectives in specific immunotherapy of melanoma", EUROPEAN JOURNAL OF CANCER, PERGAMON PRESS, OXFORD, GB, vol. 34, April 1998 (1998-04-01), pages 42 - 47, XP004284900, ISSN: 0959-8049 *
ROSENBERG S A ET AL: "Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma", NATURE MEDICINE, NATURE PUBLISHING, CO, US, vol. 4, no. 3, 1 March 1998 (1998-03-01), pages 321 - 327, XP002091661, ISSN: 1078-8956 *
See also references of WO0038515A1 *

Also Published As

Publication number Publication date
AU2016199A (en) 2000-07-31
WO2000038515A1 (en) 2000-07-06
CA2334958A1 (en) 2000-07-06
JP2002533357A (en) 2002-10-08
EP1161147A1 (en) 2001-12-12

Similar Documents

Publication Publication Date Title
HUP0003401A3 (en) Improved methods for processing activated protein c
EP1095159A4 (en) Bone morphogenic protein
GB9719879D0 (en) Protein
GB9703681D0 (en) Protein complemention
HK1039158A1 (en) Nlk1-interacting proteins
EP1018551A4 (en) Megsin protein
GB9822882D0 (en) Protein precipitation
EP1161147A4 (en) Peptide mimics useful for treating disease
PL344979A1 (en) Angiostatin-binding protein
IL123098A0 (en) Placental protein 13
ZA984322B (en) Sucrose-binding proteins
GB9715064D0 (en) Protein expression
GB9828704D0 (en) Proteins
GB9720784D0 (en) Protein
GB9816337D0 (en) Proteins
GB9809566D0 (en) Protein
GB9819038D0 (en) Protein
GB9812607D0 (en) Protein
EP1127066A4 (en) Modified proteins
GB2314014B (en) Closure-arrangements for loose-covers
GB9807760D0 (en) Disease associated protein modifications
GB9816336D0 (en) Proteins
GB9816335D0 (en) Proteins
GB9823975D0 (en) Protein
GB9816096D0 (en) Protein

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000621

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB IE IT LI NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 20020610

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB IE IT LI NL SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 01N 37/18 A, 7A 61K 38/00 B, 7A 61K 39/39 B, 7C 07K 7/00 B, 7C 12N 15/00 B

17Q First examination report despatched

Effective date: 20041221

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050701